Form 4 holding
President and CEO, Director
PRECISION BIOSCIENCES INC
- Security class
- Common Stock
- Shares / value
- 2,013,597
- Estimated value
- $745,031
- Report date
- 13 May 2021
- Price
- $0.3700
- Ownership
- Direct
Matthew R. Kane
Insider Reports History
- Reporting-owner location
- Durham, NC
- Latest reporting-owner signature
-
/s/ Dario Scimeca, Attorney-in-Fact for Matthew Kane
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Matthew R. Kane
Form 4 holding
President and CEO, Director
PRECISION BIOSCIENCES INC
- Security class
- Common Stock
- Shares / value
- 10,841
- Estimated value
- $4,011
- Report date
- 13 May 2021
- Price
- $0.3700
- Ownership
- By Spouse
Form 4 holding
President and CEO, Director
PRECISION BIOSCIENCES INC
- Security class
- Restricted Stock Units
- Shares / value
- 763
- Estimated value
- $282
- Report date
- 07 Jun 2021
- Price
- $0.3700
- Ownership
- By Spouse
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
President and CEO, Director
PRECISION BIOSCIENCES INC
- Security class
- Employee Stock Option (Right to Buy)
- Shares / value
- 1,312
- Estimated value
- Report date
- 07 Jun 2021
- Price
- Ownership
- By Spouse
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
President and CEO, Director
PRECISION BIOSCIENCES INC
- Security class
- Employee Stock Option (Right to Buy)
- Shares / value
- 0
- Estimated value
- Report date
- 13 May 2021
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Matthew R. Kane
4
DTIL
PRECISION BIOSCIENCES INC
- Report period
- 07 Jun 2021
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 09 Jun 2021, 18:37
- Role
- President and CEO, Director
- Next action
- Open filing details
4
DTIL
PRECISION BIOSCIENCES INC
- Report period
- 13 May 2021
- Transactions
- 3
- Transaction value
- -$85,827
- Accepted by SEC
- 14 May 2021, 16:50
- Role
- President and CEO, Director
- Next action
- Open filing details
4
DTIL
PRECISION BIOSCIENCES INC
- Report period
- 07 May 2021
- Transactions
- 6
- Transaction value
- -$162,172
- Accepted by SEC
- 11 May 2021, 16:27
- Role
- President and CEO, Director
- Next action
- Open filing details
4
DTIL
PRECISION BIOSCIENCES INC
- Report period
- 21 Aug 2020
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 11 Jun 2021, 17:00
- Role
- President and CEO, Director
- Next action
- Open filing details